Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Return on Capital Employed (2020 - 2024)

SELLAS Life Sciences (SLS) has disclosed Return on Capital Employed for 3 consecutive years, with 5.27% as the latest value for Q4 2022.

  • On a quarterly basis, Return on Capital Employed fell 434.0% to 5.27% in Q4 2022 year-over-year; TTM through Dec 2022 was 5.27%, a 434.0% decrease, with the full-year FY2023 number at 245.9%, up 25109.0% from a year prior.
  • Return on Capital Employed was 5.27% for Q4 2022 at SELLAS Life Sciences, down from 0.93% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.41% in Q2 2021 to a low of 5.27% in Q4 2022.
  • A 3-year average of 1.59% and a median of 0.85% in 2020 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -8bps in 2021, then crashed -434bps in 2022.
  • SELLAS Life Sciences' Return on Capital Employed stood at 0.85% in 2020, then fell by -9bps to 0.93% in 2021, then plummeted by -466bps to 5.27% in 2022.
  • Per Business Quant, the three most recent readings for SLS's Return on Capital Employed are 5.27% (Q4 2022), 0.93% (Q4 2021), and 0.5% (Q3 2021).